Moreover, NT-proBNP is established as a blood biomarker for the diagnosis and prognosis of HF, and CRP is identified as a common inflammatory factor in HF, both of which are elevated in patients with HF and valvular heart disease [40–43]. Here, CRP is linked to hydrops fetalis.